4.8 Editorial Material

Mechanism-based combination therapies for metastatic cancer

Journal

SCIENCE TRANSLATIONAL MEDICINE
Volume 14, Issue 655, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.add0887

Keywords

-

Funding

  1. European Research Council [759590]
  2. Viennese Science and Technology Fund [LS-16-063]
  3. Alex's Lemonade Stand (Crazy 8)
  4. European Union [955951]
  5. Boehringer Ingelheim
  6. Austrian Research Promotion Agency [FFG-852936]
  7. European Research Council (ERC) [759590] Funding Source: European Research Council (ERC)
  8. Marie Curie Actions (MSCA) [955951] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Functional interrogation of cancer and immune cells during tumor evolution uncovers cancer drivers and guides mechanism-based combination therapies.
Functional interrogation of cancer and immune cells during tumor evolution reveals cancer drivers and informs mechanism-based combination therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available